![Connie Chang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Connie Chang
Geschäftsführer bei ONL Therapeutics, Inc.
Aktive Positionen von Connie Chang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ONL Therapeutics, Inc.
![]() ONL Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ONL Therapeutics, Inc. develops biopharmaceutical services. It protects and improves the vision of patients with a range of retinal diseases and conditions, including retinal detachment and both the wet and dry forms of age-related macular degeneration. The company was founded by David Zacks and Jeffery Jamison in 2006 and is headquartered in Ann Arbor, MI. | Geschäftsführer | 19.01.2021 | - |
Karriereverlauf von Connie Chang
Ehemalige bekannte Positionen von Connie Chang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MILLENDO THERAPEUTICS | Corporate Officer/Principal | - | - |
Ausbildung von Connie Chang
Harvard University | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Millendo Therapeutics, Inc.
![]() Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics, Inc. is a biopharmaceutical company, which engages in seeking distinct and transformative treatments where there is a significant unmet medical need. The company was founded by Julia C. Owens in January 2012 and is headquartered in Ann Arbor, MI. | Health Technology |
ONL Therapeutics, Inc.
![]() ONL Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ONL Therapeutics, Inc. develops biopharmaceutical services. It protects and improves the vision of patients with a range of retinal diseases and conditions, including retinal detachment and both the wet and dry forms of age-related macular degeneration. The company was founded by David Zacks and Jeffery Jamison in 2006 and is headquartered in Ann Arbor, MI. | Health Technology |
- Börse
- Insiders
- Connie Chang
- Erfahrung